COMP <GO>
SMTI vs AVR // ENTERPRISE SCALE & MARKET CAP
Sanara MedTech Inc. (NASDAQ) VS. Anteris Technologies Global Corp. (NASDAQ) • 15-METRIC TALLY: SMTI 7
— AVR 2
▲ ENTERPRISE SCALE & MARKET CAP LEADER: AVR
LAST: $32.92 (+0.11%) • MKT CAP: $302.4M
market-cap
$302.4M
LAST: $6.42 (+5.25%) • MKT CAP: $625.9M
market-cap
$625.9M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SMTI VS. AVR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SMTI | AVR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 92.70% | 70.30% | +22.40 | SMTI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.30% | -35.00% | +51.30 | SMTI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 29.5x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.71% | -12.74% | +13.45 | SMTI | /fcf-yield <GO> |
| Operating Margin | 7.10% | -60.00% | +67.10 | SMTI | /operating-margins <GO> |
| Net Profit Margin | 36.40% | -60.00% | +96.40 | SMTI | /net-margins <GO> |
| Revenue Growth (YoY) | 19.00% | -29.20% | +48.20 | SMTI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.25 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 2/9 | +5.00 | SMTI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 27.3 | 41.3 | -13.96 | AVR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 6.8x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $302.4M | $625.9M | -$323.5M | AVR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SMTI REV | AVR REV | SMTI GROSS % | AVR GROSS % | SMTI FCF | AVR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $103.1M | $1.9M | 92.7% | 70.3% | $2.2M | -$79.8M |
| FY 2024 | $86.7M | $2.7M | 90.6% | 46.8% | -$229.6K | -$63.5M |
| FY 2023 | $65.0M | — | — | — | -$3.2M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SMTI // BETA —
AVR // BETA —